Table of Contents
International Scholarly Research Notices
Volume 2015 (2015), Article ID 710569, 10 pages
http://dx.doi.org/10.1155/2015/710569
Review Article

Systematic Review: Adjuvant Chemotherapy for Locally Advanced Rectal Cancer with respect to Stage of Disease

1General Surgery Department, Pilgrim Hospital, Sibsey Road, Boston, Lincolnshire PE21 9QS, UK
2General Surgery Department, Blackpool Victoria Hospital, 38 Whinney Heys Road, Blackpool, Lancashire FY3 8NR, UK

Received 24 July 2014; Revised 12 January 2015; Accepted 15 January 2015

Academic Editor: Mustafa Benekli

Copyright © 2015 Shahab Hajibandeh and Shahin Hajibandeh. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. World Health Organization, Cancer Incidence in Five Continents, The World Health Organization, The International Agency for Research on Cancer, Lyon, France, 2002.
  2. World Cancer Research Fund and American Institute for Cancer Research, Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective, American Institute for Cancer Research, Washington, DC, USA, 2007.
  3. P. Boyle and J. S. Langman, “ABC of colorectal cancer epidemiology,” British Medical Journal, vol. 321, no. 7264, pp. 805–808, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. L. A. Julien and A. G. Thorson, “Current neoadjuvant strategies in rectal cancer,” Journal of Surgical Oncology, vol. 101, no. 4, pp. 321–326, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. D. B. Stewart and D. W. Dietz, “Total mesorectal excision: what are we doing?” Clinics in Colon and Rectal Surgery, vol. 20, no. 3, pp. 190–202, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. S. H. Petersen, H. Harling, L. T. Kirkeby, P. Wille-Jørgensen, and S. Mocellin, “Postoperative adjuvant chemotherapy in rectal cancer operated for cure,” Cochrane Database of Systematic Reviews, vol. 3, Article ID CD004078, 2012. View at Google Scholar · View at Scopus
  7. National Institute for Health and Clinical Excellence (NICE), Colorectal Cancer: The Diagnosis and Management of Colorectal Cancer: Full Guideline, 2011.
  8. National Comprehensive Cancer Network, NCCN Clinical Practice Guidelines in Oncology. Rectal Cancer, National Comprehensive Cancer Network, Fort Washington, Md, USA, 2009.
  9. Methodology Checklist 2: Randomised Controlled Trials, SIGN, http://www.sign.ac.uk/methodology/checklists.html.
  10. Methodology Checklist 1: Systematic Reviews and Meta-analyses, SIGN, 2014, http://www.sign.ac.uk/methodology/checklists.html.
  11. B. Glimelius, O. Dahl, B. Cedermark et al., “Adjuvant chemotherapy in colorectal cancer: a joint analysis of randomised trials by the Nordic Gastrointestinal Tumour Adjuvant Therapy Group,” Acta Oncologica, vol. 44, no. 8, pp. 904–912, 2005. View at Google Scholar
  12. “Five-year results of a randomized controlled trial of adjuvant chemotherapy for curatively resected colorectal carcinoma. The Colorectal Cancer Chemotherapy Study Group of Japan,” Japanese Journal of Clinical Oncology, vol. 25, no. 3, pp. 91–103, 1995.
  13. B. Fisher, N. Wolmark, H. Rockette et al., “Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01,” Journal of the National Cancer Institute, vol. 80, no. 1, pp. 21–29, 1988. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Kato, Y. Ohashi, H. Nakazato et al., “Efficacy of oral UFT as adjuvant chemotherapy to curative resection of colorectal cancer: multicenter prospective randomized trial,” Langenbeck's Archives of Surgery, vol. 386, no. 8, pp. 575–581, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Kodaira, K. Kikuchi, Y. Kunii et al., “Postoperative adjuvant chemotherapy with mitomycin C and UFT for curatively resected rectal cancer. Results from the Cooperative Project No.7 Group of the Japanese Foundation for Multidisciplinary Treatment of Cancer,” International Journal of Clinical Oncology, vol. 3, no. 6, pp. 357–364, 1998. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Hamaguchi, K. Shirao, Y. Moriya, S. Yoshida, S. Kodaira, and Y. Ohashi, “Final results of randomized trials by the National Surgical Adjuvant Study of Colorectal Cancer (NSAS-CC),” Cancer Chemotherapy and Pharmacology, vol. 67, no. 3, pp. 587–596, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. Quasar Collaborative Group, R. Gray, J. Barnwell, C. McConkey, R. K. Hills, N. S. Williams et al., “Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study,” The Lancet, vol. 370, no. 9604, pp. 2020–2029, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Sakamoto, C. Hamada, S. Yoshida et al., “An individual patient data meta-analysis of adjuvant therapy with uracil-tegafur (UFT) in patients with curatively resected rectal cancer,” British Journal of Cancer, vol. 96, no. 8, pp. 1170–1177, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Watanabe, O. Nishida, Y. Kunii et al., “Randomized controlled trial of the efficacy of adjuvant immunochemotherapy and adjuvant chemotherapy for colorectal cancer, using different combinations of the intracutaneous streptococcal preparation OK-432 and the oral pyrimidines 1-hexylcarbamoyl-5-fluorouracil and uracil/tegafur,” International Journal of Clinical Oncology, vol. 9, no. 2, pp. 98–106, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. D. J. Sargent, H. S. Wieand, D. G. Haller et al., “Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials,” Journal of Clinical Oncology, vol. 23, no. 34, pp. 8664–8670, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. D. J. Sargent, S. Patiyil, G. Yothers et al., “End points for colon cancer adjuvant trials: observations and recommendations based on individual patient data from 20,898 patients enrolled onto 18 randomized trials from the ACCENT group,” Journal of Clinical Oncology, vol. 25, no. 29, pp. 4569–4574, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Kho, P. H. Chapuis, P. Beale, L. Bokey, O. F. Dent, and S. Clarke, “Use of adjuvant chemotherapy in stage C (III) rectal cancer: comparison of data from matched patients in a teaching hospital's clinico-pathological database,” Asia-Pacific Journal of Clinical Oncology, vol. 8, no. 4, pp. 346–355, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Tiselius, U. Gunnarsson, K. Smedh, B. Glimelius, and L. Påhlman, “Patients with rectal cancer receiving adjuvant chemotherapy have an increased survival: a populationbased longitudinal study,” Annals of Oncology, vol. 24, no. 1, Article ID mds278, pp. 160–165, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Sauer, H. Becker, W. Hohenberger et al., “Preoperative versus postoperative chemoradiotherapy for rectal cancer,” The New England Journal of Medicine, vol. 351, no. 17, pp. 1731–1810, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. “Adjuvant therapy for patients with colon and rectal cancer,” The Journal of the American Medical Association, vol. 264, no. 11, pp. 1444–1450, 1990. View at Scopus
  26. S. Mocellin, M. Lise, and D. Nitti, “Targeted therapy for colorectal cancer: mapping the way,” Trends in Molecular Medicine, vol. 11, no. 7, pp. 327–335, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. A. D. Wagner, D. Arnold, A. A. Grothey, J. Haerting, and S. Unverzagt, “Anti-angiogenic therapies for metastatic colorectal cancer,” Cochrane Database of Systematic Reviews, no. 3, Article ID CD005392, 2009. View at Google Scholar